Pharmacokinetics of the Anti-Inflammatory Drug Meloxicam after Single 1.5 mg/kg Intramuscular Administration to Undulate Skates (<i>Raja undulata</i>)
The therapy database currently used in elasmobranchs is still mostly based on empirical data, and there are few efficacy and safety studies supporting clinical practice. In this study, meloxicam pharmacokinetics (PK) were evaluated after a single 1.5 mg/kg IM administration to a group of seven clini...
Main Authors: | Pablo Morón-Elorza, Daniela Cañizares-Cooz, Carlos Rojo-Solis, Teresa Álvaro-Álvarez, Mónica Valls-Torres, Daniel García-Párraga, Teresa Encinas |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-04-01
|
Series: | Veterinary Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2306-7381/9/5/216 |
Similar Items
-
Pharmacokinetic Studies in Elasmobranchs: Meloxicam Administered at 0.5 mg/kg Using Intravenous, Intramuscular, and Oral Routes to Nursehound Sharks (Scyliorhinus stellaris)
by: Pablo Morón-Elorza, et al.
Published: (2022-03-01) -
Increasing the data on elasmobranch plasma protein electrophoresis: electrophoretogram reference values determination in the undulate skate (Raja Undulata) and the nursehound shark (Scyliorhinus stellaris) maintained under human care
by: Pablo Morón-Elorza, et al.
Published: (2022-10-01) -
Erratum: Pharmacokinetic studies in elasmobranchs: Meloxicam administered at 0.5 mg/kg using intravenous, intramuscular, and oral routes to nursehound sharks (Scyliorhinus stellaris)
by: Frontiers Production Office
Published: (2023-01-01) -
Natural history and molecular evolution of demersal Mediterranean sharks and skates inferred by comparative phylogeographic and demographic analyses
by: Alice Ferrari, et al.
Published: (2018-09-01) -
Strengthening Angel Shark Conservation in the Northeastern Mediterranean Sea
by: Ioannis Giovos, et al.
Published: (2022-02-01)